Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
08 2021
Historique:
received: 29 03 2021
accepted: 03 07 2021
revised: 26 08 2021
pubmed: 17 8 2021
medline: 17 11 2021
entrez: 16 8 2021
Statut: epublish

Résumé

Loa loa and Mansonella perstans-the causative agents of loiasis and mansonellosis-are vector-borne filarial parasites co-endemic in sub-Saharan Africa. Diagnosis of both infections is usually established by microscopic analysis of blood samples. It was recently established that the odds for detecting Plasmodium spp. is higher in capillary (CAP) blood than in venous (VEN) blood. In analogy to this finding this analysis evaluates potential differences in microfilaraemia of L. loa and M. perstans in samples of CAP and VEN blood. Recruitment took place between 2015 and 2019 at the CERMEL in Lambaréné, Gabon and its surrounding villages. Persons of all ages presenting to diagnostic services of the research center around noon were invited to participate in the study. A thick smear of each 10 microliters of CAP and VEN blood was prepared and analysed by a minimum of two independent microscopists. Differences of log2-transformed CAP and VEN microfilaraemia were computed and expressed as percentages. Furthermore, odds ratios for paired data were computed to quantify the odds to detect microfilariae in CAP blood versus in VEN blood. A total of 713 participants were recruited among whom 52% were below 30 years of age, 27% between 30-59 years of age and 21% above 60 years of age. Male-female ratio was 0.84. Among 152 participants with microscopically-confirmed L. loa infection median (IQR) microfilaraemia was 3,650 (275-11,100) per milliliter blood in CAP blood and 2,775 (200-8,875) in VEN blood (p<0.0001), while among 102 participants with M. perstans this was 100 (0-200) and 100 (0-200), respectively (p = 0.44). Differences in linear models amount up to an average of +34.5% (95% CI: +11.0 to +63.0) higher L. loa microfilaria quantity in CAP blood versus VEN blood and for M. perstans it was on average higher by +24.8% (95% CI: +0.0 to +60.5). Concordantly, the odds for detection of microfilaraemia in CAP samples versus VEN samples was 1.24 (95% CI: 0.65-2.34) and 1.65 (95% CI: 1.0-2.68) for infections with L. loa and M. perstans, respectively. This analysis indicates that average levels of microfilaraemia of L. loa are higher in CAP blood samples than in VEN blood samples. This might have implications for treatment algorithms of onchocerciasis and loiasis, in which exact quantification of L. loa microfilaraemia is of importance. Furthermore, the odds for detection of M. perstans microfilariae was higher in CAP than in VEN blood which may pre-dispose CAP blood for detection of M. perstans infection in large epidemiological studies when sampling of large blood quantities is not feasible. No solid evidence for a higher odds of L. loa microfilariae detection in CAP blood was revealed, which might be explained by generally high levels of L. loa microfilaraemia in CAP and VEN blood above the limit of detection of 100 microfilariae/ml. Yet, it cannot be excluded that the study was underpowered to detect a moderate difference.

Sections du résumé

BACKGROUND
Loa loa and Mansonella perstans-the causative agents of loiasis and mansonellosis-are vector-borne filarial parasites co-endemic in sub-Saharan Africa. Diagnosis of both infections is usually established by microscopic analysis of blood samples. It was recently established that the odds for detecting Plasmodium spp. is higher in capillary (CAP) blood than in venous (VEN) blood. In analogy to this finding this analysis evaluates potential differences in microfilaraemia of L. loa and M. perstans in samples of CAP and VEN blood.
METHODS
Recruitment took place between 2015 and 2019 at the CERMEL in Lambaréné, Gabon and its surrounding villages. Persons of all ages presenting to diagnostic services of the research center around noon were invited to participate in the study. A thick smear of each 10 microliters of CAP and VEN blood was prepared and analysed by a minimum of two independent microscopists. Differences of log2-transformed CAP and VEN microfilaraemia were computed and expressed as percentages. Furthermore, odds ratios for paired data were computed to quantify the odds to detect microfilariae in CAP blood versus in VEN blood.
RESULTS
A total of 713 participants were recruited among whom 52% were below 30 years of age, 27% between 30-59 years of age and 21% above 60 years of age. Male-female ratio was 0.84. Among 152 participants with microscopically-confirmed L. loa infection median (IQR) microfilaraemia was 3,650 (275-11,100) per milliliter blood in CAP blood and 2,775 (200-8,875) in VEN blood (p<0.0001), while among 102 participants with M. perstans this was 100 (0-200) and 100 (0-200), respectively (p = 0.44). Differences in linear models amount up to an average of +34.5% (95% CI: +11.0 to +63.0) higher L. loa microfilaria quantity in CAP blood versus VEN blood and for M. perstans it was on average higher by +24.8% (95% CI: +0.0 to +60.5). Concordantly, the odds for detection of microfilaraemia in CAP samples versus VEN samples was 1.24 (95% CI: 0.65-2.34) and 1.65 (95% CI: 1.0-2.68) for infections with L. loa and M. perstans, respectively.
CONCLUSION
This analysis indicates that average levels of microfilaraemia of L. loa are higher in CAP blood samples than in VEN blood samples. This might have implications for treatment algorithms of onchocerciasis and loiasis, in which exact quantification of L. loa microfilaraemia is of importance. Furthermore, the odds for detection of M. perstans microfilariae was higher in CAP than in VEN blood which may pre-dispose CAP blood for detection of M. perstans infection in large epidemiological studies when sampling of large blood quantities is not feasible. No solid evidence for a higher odds of L. loa microfilariae detection in CAP blood was revealed, which might be explained by generally high levels of L. loa microfilaraemia in CAP and VEN blood above the limit of detection of 100 microfilariae/ml. Yet, it cannot be excluded that the study was underpowered to detect a moderate difference.

Identifiants

pubmed: 34398886
doi: 10.1371/journal.pntd.0009623
pii: PNTD-D-21-00442
pmc: PMC8389422
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009623

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trop Med Parasitol. 1989 Dec;40(4):472-3
pubmed: 2696082
Trop Med Parasitol. 1990 Mar;41(1):37-9
pubmed: 2339244
J Infect Dis. 2018 Sep 8;218(8):1296-1305
pubmed: 29800345
J Trop Med Hyg. 1990 Dec;93(6):390-2
pubmed: 2270002
Trans R Soc Trop Med Hyg. 1983;77(4):463-6
pubmed: 6356501
Am J Trop Med Hyg. 1973 Mar;22(2):174-8
pubmed: 4688413
Wien Klin Wochenschr. 2021 May;133(9-10):500-508
pubmed: 33398458
Lancet Infect Dis. 2020 Jan;20(1):102-109
pubmed: 31676244
Lancet Infect Dis. 2017 Jan;17(1):108-116
pubmed: 27777031
Sci Transl Med. 2015 May 6;7(286):286re4
pubmed: 25947164
Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):506-10
pubmed: 1755060
N Engl J Med. 2017 Nov 23;377(21):2044-2052
pubmed: 29116890
Trop Med Int Health. 2018 Sep;23(9):980-991
pubmed: 29956431
Br Foreign Med Chir Rev. 1860 Apr;25(50):367-404
pubmed: 30164232
BMC Public Health. 2017 Jan 28;17(1):130
pubmed: 28129759
Ann Trop Med Parasitol. 2006 Dec;100(8):715-31
pubmed: 17227650
Lancet Infect Dis. 2014 Apr;14(4):353-7
pubmed: 24332895
Trop Med Parasitol. 1988 Dec;39(4):295-8
pubmed: 3067320
Parasitol Res. 2009 Mar;104(4):945-8
pubmed: 19107522
EClinicalMedicine. 2020 Oct 10;28:100582
pubmed: 33294807
Trop Med Int Health. 1996 Apr;1(2):264-72
pubmed: 8665395
Lancet Infect Dis. 2020 Nov;20(11):1339-1346
pubmed: 32585133
Ann Trop Med Parasitol. 1950 Dec;44(4):361-78
pubmed: 24539939
Ann Occup Hyg. 2009 Apr;53(3):249-63
pubmed: 19181626
J Glob Health. 2018 Jun;8(1):010413
pubmed: 29497506
BMJ. 1996 May 4;312(7039):1153
pubmed: 8620137
BMJ. 1996 Apr 27;312(7038):1079
pubmed: 8616417

Auteurs

Johannes Mischlinger (J)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Rella Zoleko Manego (RZ)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.

Ghyslain Mombo-Ngoma (G)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.

Dorothea Ekoka Mbassi (D)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Nina Hackbarth (N)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Franck-Aurelien Ekoka Mbassi (FA)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.

Saskia Dede Davi (SD)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Ruth Kreuzmair (R)

Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.

Luzia Veletzky (L)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Jennifer Hergeth (J)

Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.

Wilfrid Nzebe Ndoumba (WN)

Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.

Paul Pitzinger (P)

Robert Koch-Institute, Berlin, Germany.

Mirjam Groger (M)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Pierre Blaise Matsiegui (PB)

Centre de Recherches Médicales de la Ngounié (CRMN), Fougamou, Gabon.

Ayôla Akim Adegnika (AA)

Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), Partner Site Tübingen, Germany.

Selidji Todagbe Agnandji (ST)

Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany.

Bertrand Lell (B)

Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.

Michael Ramharter (M)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH